초록
Case summary:
An 83-year-old female who had uncontrolled Mooren’s ulcer invading 360 degrees of the limbus with corneal opacity received a 360-degree keratolimbal allograft (KLAL). Another 63-year-old female who had central corneal opacity and corneal neovascularization due to severe limbal cell deficiency with chemical injury received a 360-degree KLAL. During the average 17.5 months of follow-up, both eyes were tectonically maintained without severe graft rejection.
References
1. Tsai RJ, Tseng SC. Human allograft limbal transplantation for corneal surface reconstruction. Cornea. 1994; 13:389–400.
2. Son MG, Tchah HW. Combined surgery of the penetrating keratoplasty and the limbal cell transplantation. J Korean Ophthalmol Soc. 1997; 38:1112–20.
3. Lee DI, Kim KW, Kim JC. A case of autologous tragal perichon-drium graft in a patient with Mooren's ulcer. J Korean Ophthalmol Soc. 2014; 55:437–42.
4. Holland EJ, Schwartz GS, Daya SM, Djalilian A. Surgical techniques for ocular surface reconstruction. Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea. 3rd ed. Elsevier;2011; v. 2:chap. 155. 1728–44.
5. Holland EJ, Schwartz GS. The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system. Cornea. 1996; 15:549–56.
7. Kwitko S, Marinho D, Barcaro S, et al. Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology. 1995; 102:1020–5.
9. Holland EJ. Epithelial transplantation for the management of severe ocular surface disease. Trans Am Ophthalmol Soc. 1996; 94:677–743.
11. Turgeon PW, Nauheim RC, Roat MI, et al. Indications for keratoepithelioplasty. Arch Ophthalmol. 1990; 108:233–6.
12. Tsubota K, Toda I, Saito H, et al. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology. 1995; 102:1486–96.
13. Yoon JT, Tchah HW. The surgical outcomes of limbal transplantation - long term follow up study. J Korean Ophthalmol Soc. 1999; 40:1793–803.
14. Kaçmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010; 117:576–84.